Indications
Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for pain.
Composition
- Active substance
- capsaicin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Qutenza
- Active substance
- capsaicin
- ATC code
- N01BX04
- Group
- Nervous system
- Therapeutic area
- Neuralgia
- Marketing authorisation holder
- Grunenthal GmbH
- Status
- Authorised
- EU authorisation
- 15 May 2009
- EMA product number